OBJECTIVES: Abnormalities of signal transduction are considered among the susceptibility factors for bipolar disorder (BD). These include changes in G-protein-mediated signaling and subsequent modification of gene expression via transcription factors such as cAMP response element-binding protein (CREB). METHODS: We investigated levels of CREB in lymphoblasts from patients with BD, all responders to lithium prophylaxis (n = 13), and healthy control subjects (n = 15). Phosphorylated CREB (pCREB) was measured by immunoblotting in subjects with BD (n = 15) as well as in their affected (n = 17) and unaffected (n = 18) relatives, and healthy controls (n = 16). RESULTS: Basal CREB levels were comparable in patients and control subjects and were not changed by lithium treatment. pCREB levels were increased in both patients and their relatives compared to controls (p = 0.003). Forskolin stimulation led to a 24% increase in pCREB levels in cells from healthy subjects (p = 0.002) but not in the other three groups. When using basal and stimulated pCREB levels as a biochemical phenotype in a preliminary linkage study, we found the strongest support for linkage in regions largely overlapping with those showing linkage with the clinical phenotype (3p, 6p, 16p, 17q, 19q, and 21q). CONCLUSIONS: Abnormal pCREB signaling could be considered a biochemical phenotype for lithium-responsive BD.
OBJECTIVES: Abnormalities of signal transduction are considered among the susceptibility factors for bipolar disorder (BD). These include changes in G-protein-mediated signaling and subsequent modification of gene expression via transcription factors such as cAMP response element-binding protein (CREB). METHODS: We investigated levels of CREB in lymphoblasts from patients with BD, all responders to lithium prophylaxis (n = 13), and healthy control subjects (n = 15). Phosphorylated CREB (pCREB) was measured by immunoblotting in subjects with BD (n = 15) as well as in their affected (n = 17) and unaffected (n = 18) relatives, and healthy controls (n = 16). RESULTS: Basal CREB levels were comparable in patients and control subjects and were not changed by lithium treatment. pCREB levels were increased in both patients and their relatives compared to controls (p = 0.003). Forskolin stimulation led to a 24% increase in pCREB levels in cells from healthy subjects (p = 0.002) but not in the other three groups. When using basal and stimulated pCREB levels as a biochemical phenotype in a preliminary linkage study, we found the strongest support for linkage in regions largely overlapping with those showing linkage with the clinical phenotype (3p, 6p, 16p, 17q, 19q, and 21q). CONCLUSIONS: Abnormal pCREB signaling could be considered a biochemical phenotype for lithium-responsive BD.
Authors: Luis R Patino; Christina C Klein; Jeffrey R Strawn; Thomas J Blom; Maxwell J Tallman; Caleb M Adler; Jeffrey A Welge; Melissa P DelBello Journal: J Child Adolesc Psychopharmacol Date: 2021-09-14 Impact factor: 3.031
Authors: Mohammad R Nezami Ranjbar; Yue Luo; Cristina Di Poto; Rency S Varghese; Alessia Ferrarini; Chi Zhang; Naglaa I Sarhan; Hanan Soliman; Mahlet G Tadesse; Dina H Ziada; Rabindra Roy; Habtom W Ressom Journal: PLoS One Date: 2015-06-01 Impact factor: 3.240
Authors: G Pathak; M J Agostino; K Bishara; W R Capell; J L Fisher; S Hegde; B A Ibrahim; K Pilarzyk; C Sabin; T Tuczkewycz; S Wilson; M P Kelly Journal: Mol Psychiatry Date: 2016-09-20 Impact factor: 15.992
Authors: J Song; S E Bergen; A Di Florio; R Karlsson; A Charney; D M Ruderfer; E A Stahl; K D Chambert; J L Moran; K Gordon-Smith; L Forty; E K Green; I Jones; L Jones; E M Scolnick; P Sklar; J W Smoller; P Lichtenstein; C Hultman; N Craddock; M Landén; Jordan W Smoller; Roy H Perlis; Phil Hyoun Lee; Victor M Castro; Alison G Hoffnagle; Pamela Sklar; Eli A Stahl; Shaun M Purcell; Douglas M Ruderfer; Alexander W Charney; Panos Roussos; Carlos Pato Michele Pato; Helen Medeiros; Janet Sobel; Nick Craddock; Ian Jones; Liz Forty; Arianna Di Florio; Elaine Green; Lisa Jones; Katherine Gordon-Smith; Mikael Landen; Christina Hultman; Anders Jureus; Sarah Bergen; Steven McCarroll; Jennifer Moran; Jordan W Smoller; Kimberly Chambert; Richard A Belliveau Journal: Mol Psychiatry Date: 2015-10-27 Impact factor: 15.992